Home
AriBio Co., Ltd.

AriBio Co., Ltd. Market Share Analysis for May 2026

Industry: N/A

Domainaribiousa.com

Year Founded2012

Employees51 - 200

Annual Revenue--

AriBio Co., Ltd.

AriBio Co., Ltd. (including company regionals)

aribiousa.com

See more website traffic and engagement information

Total visits to AriBio Co., Ltd.'s top domains

Understand AriBio Co., Ltd. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in AriBio Co., Ltd.'s top domains

Analyze AriBio Co., Ltd. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on AriBio Co., Ltd.'s top domains

See how AriBio Co., Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

AriBio Co., Ltd. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by AriBio Co., Ltd.

These are the website technologies, by industry, used by AriBio Co., Ltd. top domains

Mobile (2)

Meta Viewport

Audio Video Media (1)

YouTube

Email Services (1)

Microsoft Exchange Online

Multilingual (1)

Multilingual Support

More Technologies

2

See all

News & Signals from AriBio Co., Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAribiousa attended event 2025 BIO International Convention on Jun 20th '25.AriBio announced on the 12th that it will participate in the 2025 BIO International Convention (hereafter BIO USA), which will be held in Boston, USA, for four days from June 16 (local time) to 19.

NewsAribiousa is developing therapeutics for kidney on May 12th '25.AriBio announced today that it has entered into a partnership with U.S.-based biotech company Restari to jointly develop new therapeutics for kidney and liver diseases, leveraging AriBio's phosphodiesterase 5 (PDE5) inhibitor technology.

NewsAribiousa partners with Kentuckyctl.SEONGNAM-SI, South Korea & LOUISVILLE, Ky.-(BUSINESS WIRE)- AriBio Co., Ltd. (AriBio) announces the expansion of testing for Alzheimer's disease by entering into a strategic collaboration with Kentucky Clinical Trial Laboratory (KCTL) for the testing of cerebral spinal fluid (CSF) to accurately and efficiently aid in the diagnosis of Alzheimer's disease using the Lumipulse(R) system from FujireBio.